Nivolumab,Ipilimumab
BMS
['ipi/', 'nivo', 'lung', 'lioi', 'cm743']
#esmo22 lung mini oral session 4-yr survival update cm743, ipi/nivo in mpm: - contd os benefit - benefit in epithelioid &amp;non epithelioid histology
- g3+ traes &lt;=5% an update on an established option, looking forward to more data on chemoio in this space 
Thoracic Oncologist focused on immunotherapy for lung cancer & immune toxicity at Beaumont RCSI Cancer Centre Dublin; Adjunct Professor Johns Hopkins University